Study title: A 6-Month Open-Label, Flexible-Dosage Study to Assess the Safety and Effectiveness of PROVIGIL® (Modafinil) Treatment in Children and Adolescents with Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea/Hyponea Syndrome.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Nervous System Diseases | |||||
| Brands: | |||||
| MAH holders: | |||||
| Assessment: | |||||
| Active substance: MODAFINIL | |||||
| ATC code: | |||||
| Document link: EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls | |||||
| Document date: 2011-09-19 | |||||
| Study number: C1538/3034/ES/MN | |||||
| EudraCT number: | |||||
| Scope of study: | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | Y | |